medRxiv

Antibody prevalence after 3 or more COVID-19 vaccine doses in 23,000 immunosuppressed individuals: a cross-sectional study from MELODY medrxiv.org/content/10.1101/20

· · medRxiv article feed · 0 · 0 · 0
Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.

Trending now

Resources

Developers

What is Mastodon?

social.cleverlibre.org

More…

v3.5.19-qoto · Privacy policy